Agreements

Ref: NEPHROPLUS/SE/93 October 27, 2026 To To BSE Limited National Stock Exchange of India Limited P.J. Towers, Dalal Street, 5th Floor, Exchange Plaza, Bandra (E), Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 544647 Scrip Symbol: NEPHROPLUS Through: BSE Listing Centre Through: NEAPS Subject: Disclosure under Regulation 30 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’) Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 (“SEBI Master Circular”), we hereby inform you that Nephrocare Health Care Services, Philippines Inc., an overseas step-down wholly-owned subsidiary of Nephrocare Health Services Limited (“the Company”), has entered into an Asset Transfer Agreement (“ATA”) dated October 27, 2026 with JCM Summit Health Inc., for the acquisition of identified assets relating to a dialysis center located at Don Mariano Marcos Avenue, Quezon City, Philippines (the “Transaction”), subject to the terms and conditions set out therein. The value of the Transaction exceeds the materiality threshold determined in accordance with the Company’s Policy for Determination of Materiality of Events/Information. The consideration payable under the ATA is not being disclosed, as the same constitutes confidential and commercially sensitive information, the disclosure of which may adversely affect the competitive position of the Company in the market. The details as required under Regulation 30 of the SEBI Listing Regulations read with the aforesaid SEBI Master Circular are enclosed herewith as Annexure I. The aforesaid information is also being made available on the Company’s website at www.nephroplus.com. For Nephrocare Health Services Limited (Formerly Nephrocare Health Services Private Limited) Kishore Kathri Company Secretary & Head Legal ICSI M. No. F9895 ANNEXURE I Sr. Particulars Description 1. Name(s) of parties with whom the Nephrocare Health Care Services, agreement is entered Philippines Inc. (an overseas step-down wholly-owned subsidiary of the Company) (“Purchaser”) and JCM Summit Health Inc. (“Seller”) 2. Purpose of entering into the Acquisition of the dialysis center assets agreement pursuant to the ATA (the “Transaction”), in accordance with and subject to the terms and conditions stipulated therein. 3. Size of agreement The value of the Transaction exceeds the materiality threshold determined in accordance with the Company’s Policy for Determination of Materiality of Events/Information. The consideration has not been disclosed, as the same constitutes confidential and commercially sensitive information, the disclosure of which may adversely affect the competitive position of the Company in the market. 4. Shareholding, if any, in the entity Not Applicable with whom the agreement is executed 5. Significant terms of the No special rights have been granted under agreement (in brief) special rights the ATA. like right to appoint directors, first right to share subscription in case of issuance of shares, right to restrict any change in capital structure etc.; 6. Whether, the said parties are The Purchaser is an overseas step-down related to promoter/promoter wholly-owned subsidiary of the Company. group/ group companies in any manner. If yes, nature of The Seller is not related to the relationship; promoter/promoter group/group companies of the Company in any manner. 7. Whether the transaction would fall No within related party transactions? If yes, whether the same is done at “arm’s length” 8. In case of issuance of shares to Not Applicable the parties, details of issue price, class of shares issued; 9. In case of loan agreements, details Not Applicable of lender/borrower, nature of the loan, total amount of loan granted/taken, total amount outstanding, date of execution of the loan agreement/sanction letter, details of the security provided to the lenders / by the borrowers for such loan or in case outstanding loans lent to a party or borrowed from a party become material on a cumulative basis; 10. Any other disclosures related to Not Applicable such agreements, viz., details of nominee on the board of directors of the listed entity, potential conflict of interest arising out of such agreements, etc. 11. In case of termination or Not Applicable amendment of agreement, listed entity shall disclose additional details to the stock exchange(s): a. Name of parties to the agreement; b. Nature of the agreement; c. Date of execution of the agreement; d. Details of amendment and impact thereof or reasons of termination and impact thereof.